Differential targeting of the HSV1 vhs endoribonuclease - preferential degradation of cellular transcripts on the endoplasmic reticulum?
HSV1 vhs 核糖核酸内切酶的差异靶向 - 在内质网上优先降解细胞转录物?
基本信息
- 批准号:MR/T001038/1
- 负责人:
- 金额:$ 65.14万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2020
- 资助国家:英国
- 起止时间:2020 至 无数据
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Herpes simplex virus (HSV) is an important human pathogen of medical and economic impact. HSV infection is life-long and once acquired it remains dormant in the body, poised to re-emerge and cause disease. It is the causative agent of recurring oral and genital herpes, both of which have profound effects on the quality of life of sufferers. Upon activation, HSV can also have much more serious consequences. For example, it is a pioneer infection for human immunodeficiency virus (HIV), making individuals more susceptible to HIV infection. It is the major cause of infectious blindness, and viral encephalitis that results in death or devastating brain damage. In developing countries neonatal herpes remains a cause of death in newborns. Individuals who have a suppressed immune system, such as transplant, cancer chemotherapy, and AIDS patients, are particularly susceptible to complications of HSV. With 24 million new cases globally each year, this virus is a huge economic burden on our health systems. However, efforts to develop an HSV vaccine have, without exception, failed. Moreover, although drug treatments for HSV have existed for decades, their use has made no impact on this HSV epidemic and resistance is growing. It is therefore vital that new ways to treat HSV are identified.To understand how to treat virus infections, it is first important to understand how they cause disease. HSV produces a number of factors that are considered non-essential for infection in cells in the lab, but are vital for the virus to cause disease in the host animal. These factors represent new targets for therapuetic intervention. One of these is virion host shutoff (vhs), which has a role in controlling the global cellular environment to make it favourable for efficient virus growth. Nonetheless, it is not yet clear how vhs activity influences the outcome of the disease process in a balanced fashion, such that it does not create a hostile environment for the virus. Using a global approach to look at cellular changes in HSV1 infection, we have discovered that vhs appears to target specific groups of cellular factors involved in pathways that determine the make-up of the environment outside the cell. Here, we propose to use state-of-the-art technology to define in detail the targets that are highly susceptible to vhs activity. New tools will be developed to identify the infected cell components that interact with vhs to understand how vhs is targeted to its site of action. Finally, we will determine if the activity of vhs prepares the cell to make large numbers of virus structual components thereby enabling the efficient production of new virus particles. In this way we aim to unravel the complexities of vhs activity to further our understanding of its role in virus infection and identify target interactions to potentially inhibit therapeutically.
单纯疱疹病毒(HSV)是一种重要的人类病原体,对医学和经济都有很大影响。HSV感染是终身的,一旦获得,它在体内保持休眠状态,随时可能重新出现并引起疾病。它是复发性口腔和生殖器疱疹的病原体,两者对患者的生活质量都有深远的影响。一旦激活,HSV也可能产生更严重的后果。例如,它是人类免疫缺陷病毒(HIV)的先驱感染,使个人更容易感染HIV。它是传染性失明和病毒性脑炎的主要原因,病毒性脑炎导致死亡或毁灭性的脑损伤。在发展中国家,新生儿疱疹仍然是新生儿死亡的一个原因。免疫系统受抑制的个体,如移植、癌症化疗和艾滋病患者,特别容易患HSV并发症。全球每年有2400万新病例,这种病毒给我们的卫生系统带来了巨大的经济负担。然而,开发HSV疫苗的努力无一例外都失败了。此外,尽管HSV的药物治疗已经存在了几十年,但它们的使用对HSV的流行没有影响,而且耐药性正在增长。因此,找到治疗HSV的新方法是至关重要的。要了解如何治疗病毒感染,首先要了解它们是如何引起疾病的。HSV产生许多因子,这些因子被认为是实验室中细胞感染的非必需因子,但对于病毒在宿主动物中引起疾病至关重要。这些因素代表了治疗干预的新目标。其中之一是病毒体宿主关闭(vhs),它在控制整个细胞环境中发挥作用,使其有利于病毒的有效生长。尽管如此,目前还不清楚vhs活性如何以平衡的方式影响疾病过程的结果,这样它就不会为病毒创造一个敌对的环境。使用全局方法来观察HSV 1感染中的细胞变化,我们发现vhs似乎靶向参与决定细胞外环境组成的途径的特定细胞因子组。在这里,我们建议使用最先进的技术来详细定义对vhs活动高度敏感的目标。将开发新的工具来识别与vhs相互作用的感染细胞成分,以了解vhs是如何靶向其作用部位的。最后,我们将确定vhs的活性是否使细胞准备好制造大量的病毒结构成分,从而使新病毒颗粒的有效生产成为可能。通过这种方式,我们的目标是解开vhs活性的复杂性,以进一步了解其在病毒感染中的作用,并确定潜在的治疗抑制靶点相互作用。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Translational arrest and mRNA decay are independent activities of alphaherpesvirus virion host shutoff proteins
翻译停滞和 mRNA 衰减是 α-疱疹病毒病毒粒子宿主关闭蛋白的独立活动
- DOI:10.1101/2024.02.02.578636
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Eke L
- 通讯作者:Eke L
Dysregulated nuclear export of the late herpes simplex virus 1 transcriptome through the vhs-VP22 axis uncouples virus cytopathic effect and virus production
晚期单纯疱疹病毒1转录组通过vhs-VP22轴的核输出失调,使病毒细胞病变效应和病毒产生脱钩
- DOI:10.1101/2022.11.02.514834
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Pheasant K
- 通讯作者:Pheasant K
Herpes Simplex Virus 1 Expressing GFP-Tagged Virion Host Shutoff (vhs) Protein Uncouples the Activities of RNA Degradation and Differential Nuclear Retention of the Virus Transcriptome.
- DOI:10.1128/jvi.01926-21
- 发表时间:2022-07-27
- 期刊:
- 影响因子:5.4
- 作者:Wise, Emma L.;Samolej, Jerzy;Elliott, Gillian
- 通讯作者:Elliott, Gillian
Herpes simplex virus 1 expressing GFP-tagged virion host shutoff (vhs) protein uncouples the activities of degradation and nuclear retention of the infected cell transcriptome
单纯疱疹病毒 1 表达 GFP 标记的病毒颗粒宿主关闭 (vhs) 蛋白,解开受感染细胞转录组的降解和核保留活动
- DOI:10.1101/2022.01.04.475014
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Wise E
- 通讯作者:Wise E
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gill Elliott其他文献
Parental knowledge of alcohol consumption: a cross sectional survey of 11–17 year old schoolchildren and their parents
家长饮酒知识:11-17岁学童及其家长的横断面调查
- DOI:
- 发表时间:
2013 - 期刊:
- 影响因子:4.5
- 作者:
Michela Morleo;P. Cook;Gill Elliott;P. Phillips - 通讯作者:
P. Phillips
Spatial proteomics identifies a CRTC-dependent viral signaling pathway that stimulates production of interleukin-11
空间蛋白质组学鉴定出一种依赖 CRTC 的病毒信号通路,该通路可刺激白细胞介素-11 的产生。
- DOI:
10.1016/j.celrep.2025.115263 - 发表时间:
2025-02-25 - 期刊:
- 影响因子:6.900
- 作者:
Benjamin J. Ravenhill;Marisa Oliveira;George Wood;Ying Di;Joanne Kite;Xinyue Wang;Colin T.R. Davies;Yongxu Lu;Robin Antrobus;Gill Elliott;Nerea Irigoyen;David J. Hughes;Paul A. Lyons;Betty Chung;Georg H.H. Borner;Michael P. Weekes - 通讯作者:
Michael P. Weekes
Going beyond the syllabus: a study of A level Mathematics teachers and students
超越教学大纲:A-level数学教师和学生的研究
- DOI:
10.1080/03055698.2011.643108 - 发表时间:
2012 - 期刊:
- 影响因子:1.7
- 作者:
Irenka Suto;Gill Elliott;Nicky Rushton;Sanjana Mehta - 通讯作者:
Sanjana Mehta
Gill Elliott的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gill Elliott', 18)}}的其他基金
High-throughput digital microplate microscopy reader for the study of cellular responses to infection and stress
高通量数字微孔板显微镜阅读器,用于研究细胞对感染和应激的反应
- 批准号:
MR/X013588/1 - 财政年份:2022
- 资助金额:
$ 65.14万 - 项目类别:
Research Grant
Impact of a viral endoribonuclease on the nucleocytoplasmic compartmentalisation of the cellular transcriptome
病毒核糖核酸内切酶对细胞转录组核质区室化的影响
- 批准号:
BB/T007923/1 - 财政年份:2020
- 资助金额:
$ 65.14万 - 项目类别:
Research Grant
Characterisation of novel virus-host cell interactions essential for herpes simplex virus envelopment
单纯疱疹病毒包膜所必需的新型病毒-宿主细胞相互作用的表征
- 批准号:
MR/M020061/1 - 财政年份:2016
- 资助金额:
$ 65.14万 - 项目类别:
Research Grant
Characterising the Mode of Action of VP22 - a Novel Herpes Simplex Virus Virulence Factor Important for In Vivo Replication.
VP22 的作用模式的表征 - 一种对体内复制很重要的新型单纯疱疹病毒毒力因子。
- 批准号:
MR/M011607/1 - 财政年份:2015
- 资助金额:
$ 65.14万 - 项目类别:
Research Grant
Investigation of cellular nucleocytoplasmic transport pathways using the alphaherpesvirus UL47 group of proteins.
使用α疱疹病毒 UL47 组蛋白研究细胞核细胞质转运途径。
- 批准号:
BB/E016251/1 - 财政年份:2007
- 资助金额:
$ 65.14万 - 项目类别:
Research Grant
Characterisation of herpes simplex virus morphogenesis by tracking the virus tegument through the secretory pathway
通过分泌途径追踪病毒外皮来表征单纯疱疹病毒形态发生
- 批准号:
G0601605/1 - 财政年份:2007
- 资助金额:
$ 65.14万 - 项目类别:
Fellowship
相似国自然基金
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
- 批准号:82373145
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
诱导性多能干细胞rDNA区基因打靶在线粒体视神经病中的治疗研究
- 批准号:81970829
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
Pre-targeting/Click反应介导的自体循环干细胞在心脏缺血损伤修复中的应用及机制研究
- 批准号:81873493
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
以IGF2/IGF1R与SYT/SSX1为靶点治疗滑膜肉瘤的实验研究
- 批准号:81102033
- 批准年份:2011
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
基于ZFN/phiC31系统的新型基因打靶技术的建立(果蝇)
- 批准号:31171278
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Fragment to small molecule hit discovery targeting Mycobacterium tuberculosis FtsZ
针对结核分枝杆菌 FtsZ 的小分子片段发现
- 批准号:
MR/Z503757/1 - 财政年份:2024
- 资助金额:
$ 65.14万 - 项目类别:
Research Grant
Targeting metabolism to improve the host response to peritoneal dialysis
靶向代谢以改善宿主对腹膜透析的反应
- 批准号:
MR/Y013816/1 - 财政年份:2024
- 资助金额:
$ 65.14万 - 项目类别:
Research Grant
Targeting Inhibitory kappa B kinase alpha (IKKalpha): a new treatment paradigm for inflammatory-driven cancers
靶向抑制性 kappa B 激酶 alpha (IKKalpha):炎症驱动的癌症的新治疗范例
- 批准号:
MR/Y015479/1 - 财政年份:2024
- 资助金额:
$ 65.14万 - 项目类别:
Research Grant
Development of a novel cancer immunotherapy model targeting human macrophages
开发针对人类巨噬细胞的新型癌症免疫治疗模型
- 批准号:
24K18516 - 财政年份:2024
- 资助金额:
$ 65.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
- 批准号:
10752046 - 财政年份:2024
- 资助金额:
$ 65.14万 - 项目类别:
Greatwall in replication stress/DNA damage responses and oral cancer resistance
长城在复制应激/DNA损伤反应和口腔癌抵抗中的作用
- 批准号:
10991546 - 财政年份:2024
- 资助金额:
$ 65.14万 - 项目类别:
Genetic targeting of a synthetic dye for voltage imaging of cerebellar Purkinje neurons during a tongue grasping task
一种合成染料的基因靶向,用于抓取舌头任务期间小脑浦肯野神经元的电压成像
- 批准号:
23K27147 - 财政年份:2024
- 资助金额:
$ 65.14万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 65.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Optimisation of small molecule inhibitors for effective targeting of phospholipase C gamma in T-cell lymphoma
优化小分子抑制剂以有效靶向 T 细胞淋巴瘤中的磷脂酶 C γ
- 批准号:
MR/Y503344/1 - 财政年份:2024
- 资助金额:
$ 65.14万 - 项目类别:
Research Grant
Targeting soluble guanylate cyclase as a novel strategy to treat and prevent cardiac arrhythmias: efficacy and mechanisms
靶向可溶性鸟苷酸环化酶作为治疗和预防心律失常的新策略:功效和机制
- 批准号:
MR/Y003594/1 - 财政年份:2024
- 资助金额:
$ 65.14万 - 项目类别:
Research Grant














{{item.name}}会员




